(S)-1-Amino-3-methyl-4,5-dihydro-1H-benzo[d]azepin-2(3H)-one hydrochloride, 98%, 100mg

4-Oxo-4-piperidin-1-yl-butyric acid, 98.0%, 2g

2-Methoxy-3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridine, 98+%, 1g

4-Chloro-3-fluoro-1H-pyrrolo[2,3-b]pyridine, 95.0%, 1g

4-Bromo-3-fluoro-2-methylpyridine, 95.0%, 1g

5-Ethyl-2-[2-(4-nitrophenoxy)ethyl]pyridine>98.0%(GC)5g

Chloropentafluorobenzene, 99.0%, 25g

Sodium 2-(4-(2-((3,5-dimethylphenyl)amino)-2-oxoethyl)phenoxy)-2-methylpropanoate, 95.0%, 50mg

(S)-(-)-2-Amino-3-methyl-1,1-diphenyl-1-butanol>98.0%(HPLC)(T)1g

1,5-Dimethyl-1H-pyrazol-4-amine hydrochloride, 95.0%, 1g

1-(5-Amino-2-hydroxyphenyl)ethanone, 95.0%, 5g

Tributylamine, min. 99%, for synthesis, 500 ml, glass packaging

2,5-Bis(trifluoromethyl)aniline, 97.0%, 25g